It's not meaningless to the intellectual community. I'm sure that AVXL's research is providing a lot of great information.
It's meaningless to the stock market, and to our vested interest in seeing the share price go up.
The market clearly agrees with my sentiment, otherwise we'd be green. Instead it's back in the 2s, it broke the $2.89 support, and the sky is fallllllllllling lol.
My point is that from a financial perspective nothing changes with this new information. Nobody's rushing in to put money in Anavex because it restores gut bacteria function. Maybe it's another indication that Anavex is effective, maybe it's all a coincidence, but we've had plenty of indications now that the drug works and ample time for people to invest if they wish -- but they aren't going to until the risk is diminished. This information doesn't diminish any risk, the drug is still just as likely to fail or succeed today as it was last week.
News 
Market Data 
Discover 
AI
